223 related articles for article (PubMed ID: 19035773)
21. Natural and synthetic compounds as dissociated agonists of glucocorticoid receptor.
Zhang T; Liang Y; Zhang J
Pharmacol Res; 2020 Jun; 156():104802. PubMed ID: 32278042
[TBL] [Abstract][Full Text] [Related]
22. New steroidal antiinflammatory antedrugs: Methyl 3,20-dioxo-9 alpha-fluoro-11 beta,17 alpha,21-trihydroxy-1,4-pregnadiene-16 alpha-carboxylate and its 21-O-acyl derivatives.
Ko DH; Heiman AS; Hudson CE; Lee HJ
Steroids; 2002 Mar; 67(3-4):211-9. PubMed ID: 11856545
[TBL] [Abstract][Full Text] [Related]
23. Antedrugs: an approach to safer drugs.
Khan MO; Park KK; Lee HJ
Curr Med Chem; 2005; 12(19):2227-39. PubMed ID: 16178782
[TBL] [Abstract][Full Text] [Related]
24. In vitro anti-inflammatory activities of new steroidal antedrugs: [16alpha,17alpha-d] Isoxazoline and [16alpha,17alpha-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of prednisolone and 9alpha-fluoroprednisolone.
Park KK; Ko DH; You Z; Khan MO; Lee HJ
Steroids; 2006 Mar; 71(3):183-8. PubMed ID: 16309722
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory profile of some synthesized heterocyclic pyridone and pyridine derivatives fused with steroidal structure.
Amr AG; Abdulla MM
Bioorg Med Chem; 2006 Jul; 14(13):4341-52. PubMed ID: 16545570
[TBL] [Abstract][Full Text] [Related]
26. The search for safer glucocorticoid receptor ligands.
Rosen J; Miner JN
Endocr Rev; 2005 May; 26(3):452-64. PubMed ID: 15814846
[TBL] [Abstract][Full Text] [Related]
27. Novel cytokine release inhibitors. Part II: Steroids.
He W; Huang FC; Morytko M; Jariwala N; Yu KT
Bioorg Med Chem Lett; 1998 Oct; 8(20):2825-8. PubMed ID: 9873630
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of new prodrugs of etodolac and tolfenamic acid with reduced ulcerogenic potential.
Hassib ST; Hassan GS; El-Zaher AA; Fouad MA; Abd El-Ghafar OA; Taha EA
Eur J Pharm Sci; 2019 Dec; 140():105101. PubMed ID: 31639436
[TBL] [Abstract][Full Text] [Related]
29. 5-Functionalized indazoles as glucocorticoid receptor agonists.
Bai M; Carr G; Deorazio RJ; Friedrich TD; Dobritsa S; Fitzpatrick K; Guzzo PR; Kitchen DB; Lynch MA; Peace D; Sajad M; Usyatinsky A; Wolf MA
Bioorg Med Chem Lett; 2010 May; 20(10):3017-20. PubMed ID: 20427184
[TBL] [Abstract][Full Text] [Related]
30. A novel approach to the discovery of non-systemic anti-inflammatory steroids; antedrug.
Lee HJ; Ko DH
Arch Pharm Res; 1999 Jun; 22(3):279-87. PubMed ID: 10403131
[TBL] [Abstract][Full Text] [Related]
31. Macrolactonolides: a novel class of anti-inflammatory compounds.
Tomašković L; Komac M; Makaruha Stegić O; Munić V; Ralić J; Stanić B; Banjanac M; Marković S; Hrvačić B; Čipčić Paljetak H; Padovan J; Glojnarić I; Eraković Haber V; Mesić M; Merćep M
Bioorg Med Chem; 2013 Jan; 21(1):321-32. PubMed ID: 23199485
[TBL] [Abstract][Full Text] [Related]
32. One-pot three-component synthesis of novel heterocyclic steroids as a central antioxidant and anti-inflammatory agents.
Mohamed NR; Abdelhalim MM; Khadrawy YA; Elmegeed GA; Abdel-Salam OM
Steroids; 2012 Nov; 77(13):1469-76. PubMed ID: 22999991
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of modified steroids as a novel class of non-ulcerogenic, anti-inflammatory and anti-nociceptive agents.
Mohareb RM; Elmegeed GA; Abdel-Salam OM; Doss SH; William MG
Steroids; 2011; 76(10-11):1190-203. PubMed ID: 21664368
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, docking and anti-inflammatory evaluation of novel series of benzofuran based prodrugs.
Yadav P; Singh P; Tewari AK
Bioorg Med Chem Lett; 2014 May; 24(10):2251-5. PubMed ID: 24745964
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of anti-inflammatory, anti-nociceptive, and anti-ulcerogenic activities of novel synthesized thiazolyl and pyrrolyl steroids.
Mohareb RM; Elmegeed GA; Baiuomy AR; Eskander EF; William MG
Arch Pharm (Weinheim); 2011 Sep; 344(9):595-604. PubMed ID: 21887799
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the design and synthesis of prednisolone and methylprednisolone conjugates.
Bílková E; Imramovský A; Sedlák M
Curr Pharm Des; 2011; 17(32):3577-95. PubMed ID: 22074428
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, hydrolysis studies and phamacodynamic profiles of amide prodrugs of dexibuprofen with amino acids.
Rasheed A; Kumar CK; Mishra A
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):688-95. PubMed ID: 21250819
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of novel D-ring substituted steroidal pyrazolines as potential anti-inflammatory agents.
Cai X; Zhao S; Cai D; Zheng J; Zhu Z; Wei D; Zheng Z; Zhu H; Chen Y
Steroids; 2019 Jun; 146():70-78. PubMed ID: 30951758
[TBL] [Abstract][Full Text] [Related]
39. Expeditious synthesis of steroids containing a 2-methylsulfanyl-acetyl side chain as potential glucocorticoid receptor imaging agents.
Wuest F; Carlson KE; Katzenellenbogen JA
Steroids; 2008 Jan; 73(1):69-76. PubMed ID: 17942130
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of anthraquinone-ibuprofen prodrugs with hydroxyapatite affinity and anti-inflammatory activity characteristics.
Duan Y; Yu J; Liu S; Ji M
Med Chem; 2009 Nov; 5(6):577-82. PubMed ID: 19673691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
